CIK 0001816736 · Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 851612845
- Phone
- (617) 674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,489,047
- in 7 filings, $12.6M under 10b5-1 plans
Net −$14,489,047. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-12 | Bitterman Kevin Director | Sale | −8,527 | $92.05 | $785K | 377,022 |
| 2025-12-12 | Bitterman Kevin Director | Sale | −2,005 | $92.58 | $186K | 375,017 |
| 2025-12-12 | Bitterman Kevin Director | Sale | −1,793 | $93.80 | $168K | 373,224 |
| 2025-12-12 | Bitterman Kevin Director | Sale | −6,570 | $92.05 | $605K | 44,430 |
| 2025-12-12 | Bitterman Kevin Director | Sale | −1,540 | $92.58 | $143K | 42,890 |
| 2025-12-12 | Bitterman Kevin Director | Sale | −1,371 | $93.80 | $129K | 41,519 |
| 2025-12-11 | Quisel John D Chief Executive Officer | Option exercise 10b5-1 | +40,000 | $9.86 | $394K | 211,828 |
| 2025-12-11 | Quisel John D Chief Executive Officer | Sale 10b5-1 | −2,419 | $90.97 | $220K | 209,409 |
| 2025-12-11 | Quisel John D Chief Executive Officer | Sale 10b5-1 | −4,337 | $92.21 | $400K | 205,072 |
| 2025-12-11 | Quisel John D Chief Executive Officer | Sale 10b5-1 | −16,356 | $92.96 | $1.5M | 188,716 |
| 2025-12-11 | Quisel John D Chief Executive Officer | Sale 10b5-1 | −16,888 | $93.65 | $1.6M | 171,828 |
| 2025-12-11 | Quisel John D Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −40,000 | 75,375 | ||
| 2025-11-11 | Yu Jonathan Yen-Wen Chief Operating Officer | Option exercise 10b5-1 | +30,000 | $2.65 | $80K | 70,555 |
| 2025-11-11 | Yu Jonathan Yen-Wen Chief Operating Officer | Sale 10b5-1 | −8,015 | $83.15 | $666K | 62,540 |
| 2025-11-11 | Yu Jonathan Yen-Wen Chief Operating Officer | Sale 10b5-1 | −4,585 | $83.99 | $385K | 57,955 |
| 2025-11-11 | Yu Jonathan Yen-Wen Chief Operating Officer | Sale 10b5-1 | −9,360 | $85.33 | $799K | 48,595 |
| 2025-11-11 | Yu Jonathan Yen-Wen Chief Operating Officer | Sale 10b5-1 | −8,040 | $85.91 | $691K | 40,555 |
| 2025-11-11 | Yu Jonathan Yen-Wen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,000 | 7,941 | ||
| 2025-10-22 | AI DMI LLC 10% owner | Sale | −744,047 | $80.47 | $59.9M | 2,814,379 |
| 2025-10-17 | Bitterman Kevin Director | Sale | −1,125 | $84.89 | $96K | 475,911 |
Page 9 of 17 · 337 trades